Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7241
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants ; volume:30 ; number:2 ; day:18 ; month:1 ; year:2016 ; pages:201-214 ; date:4.2016
Cardiovascular drugs and therapy ; 30, Heft 2 (18.1.2016), 201-214, 4.2016
- Creator
-
Morais, João
- Contributor
-
De Caterina, Raffaele
SpringerLink (Online service)
- DOI
-
10.1007/s10557-015-6632-3
- URN
-
urn:nbn:de:1111-201605064877
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Morais, João
- De Caterina, Raffaele
- SpringerLink (Online service)
Other Objects (12)
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
Stroke prevention in atrial fibrillation
Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
Baseline characteristics in stroke patients with atrial fibrillation: clinical trials versus clinical practice
Reporting quality of randomized controlled trials evaluating non-vitamin K oral anticoagulants in atrial fibrillation: a systematic review
Outcomes of mechanical thrombectomy in acute stroke patients with atrial fibrillation detected after stroke versus known atrial fibrillation
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
Stroke prevention in atrial fibrillation
Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
Baseline characteristics in stroke patients with atrial fibrillation: clinical trials versus clinical practice
Reporting quality of randomized controlled trials evaluating non-vitamin K oral anticoagulants in atrial fibrillation: a systematic review
Outcomes of mechanical thrombectomy in acute stroke patients with atrial fibrillation detected after stroke versus known atrial fibrillation
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
Stroke prevention in atrial fibrillation
Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
Baseline characteristics in stroke patients with atrial fibrillation: clinical trials versus clinical practice
Reporting quality of randomized controlled trials evaluating non-vitamin K oral anticoagulants in atrial fibrillation: a systematic review